Go To Content
  • facebook
  • Google
  • Line
  • Twitter
  • Forward
  • Print

Safety information

GMP alerts

【Update Date:2015-09-10】 unit:品質監督管理組

If the Critical deficiency of GMP is directly related to the risk of product quality and the drug safety by public, the government will force some of the products, formulations, or whole industry to stop producing or selling. The Guidelines will be based on recalling assignments to require that the pharmaceutical industries should recall the products and report to the government in period, and the recall products are not allowed circulating in the market.
The government will supervise various improvement measures of pharmaceutical industries and continue the follow-up management of implementation to ensure the drug safety by public. Subsequent inspection results of industry will be announced in order to provide a reference for consumers to use drugs.